financetom
Business
financetom
/
Business
/
Cruise line Norwegian shakes up board amid pressure from activist Elliott
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cruise line Norwegian shakes up board amid pressure from activist Elliott
Mar 27, 2026 11:37 AM

* Five new directors, including 4 proposed by Elliott,

will join board

* Elliott supports new CEO John Chidsey's leadership

* Elliott pushed for better guest experience, improved

financial results

(Adds details on new directors, Elliott's requests, background

on past campaigns)

By Svea Herbst-Bayliss

March 27 (Reuters) - Norwegian Cruise Line Holdings ( NCLH )

is shaking up its board to improve performance amid

pressure from activist investor Elliott Investment Management.

The world's third-largest cruise operator said on Friday it

will add five new directors at the end of the month, including

executives with experience in running an airline, a theme park

and an investor who has expertise in taking companies private.

Last month Elliott, one of the world's busiest activist

investors with approximately $80 billion in assets, unveiled its

more than 10% stake in Norwegian alongside calls for management

to improve the guest experience and financial results.

Earlier this month, Elliott, now Norwegian's largest

shareholder, called for a board overhaul after the company

reported lower profits and a weak outlook for 2026.

The cruise operator warned on Friday that rising fuel costs

linked to geopolitical uncertainties would weigh on profits this

year and that new reservations had slowed as consumers face

rising prices and are watching their spending more.

Chief Executive John Chidsey, who has been credited with

previously turning around sandwich chain Subway and was

appointed to the cruise line's top job in February, will be

given the additional title of chairman of the board.

Alex Cruz, a former chief executive of British Airways, will

become lead independent director. Former Disney Experiences

chief financial officer Kevin Lansberry, Steve Pagliuca, a

former managing partner of private equity giant Bain Capital,

Brian MacDonald, president of integrated software provider CDK

Global and Jonathan Cohen, founder and chief executive of

investment firm Hepco Capital Management, will also join the

board on March 31.

Four long-serving directors, including Stella David who had

been the chairperson, will leave.

The change in directors marks one of the most dramatic

reshaping of a board since 2024 when five of Elliott's 10

nominees became directors at Southwest Airlines after the hedge

fund threatened a proxy fight.

Norwegian has a market value of roughly $8.6 billion and its

stock price has fallen nearly 30% in the last five years. Its

much bigger rival Royal Caribbean Cruises ( RCL ) saw its stock

price surge 211% during the same time.

Elliott, which is also currently pushing for changes at

software company Synopsys ( SNPS ) and orthodontics company

Align Technology ( ALGN ), wanted Norwegian to develop and

implement a new business plan to better compete with rivals and

to have leadership in place to oversee a successful

transformation.

Elliott previously said the right kind of changes could help

Norwegian's stock price surge to $56 a share, compared to

its$18.81 per share price on Friday.

"We see the potential for significant value creation ahead

under (CEO John Chidsey's) leadership," Elliott partner John

Pike said, adding that the new board will help restore investor

confidence.

While Elliott is foremost focused on operational

improvements at Norwegian, industry analysts said the reshaped

board's expertise in taking companies private might also signal

readiness to pursue a sale at some point in the future.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved